Opioid painkillers provide little relief for sufferers of low back pain, even in high doses. This is the primary finding of…
Read more
NSAID labelling review The TGA has announced it will be reviewing product information and labelling for non-steroidal…
Read more
Public consultation is being sought for proposals to warn of cardiovascular and hepatic disease risks from prolonged NSAID…
Read more
The TGA is to take a second look at the status of diclofenac following the UK's decision to ban over-the-counter sales of…
Read more
Up to a third of patients are unable to follow simple dosing instructions for common rheumatology medications, Australian…
Read more
Experts are calling for NSAID warning labels to be expanded to include risks for people with renal complications, while a…
Read more
Non-steroidal anti-inflammatory drugs (NSAIDs), one of the most commonly used classes of drugs in Australia, are…
Read more